Stockreport

Genentech in up to $1.7B RNAi licensing deal with SanegeneBio [Seeking Alpha]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Terms call for Genentech to make a $200M upfront payment. Sanegene is eligible for up to $1.5B in milestone payments, plus tiered royalties. Recommended For You Mor [Read more]